Felkai Chelsea, Newby David, Cooper Joyce, Nielsen Suzanne, Reeves Angela, Croft Hayley
School of Biomedical Sciences and Pharmacy, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW 2308, Australia.
College of Medicine and Dentistry, Division of Tropical Health and Medicine, James Cook University, QLD 4811, Australia.
Explor Res Clin Soc Pharm. 2024 Aug 13;15:100489. doi: 10.1016/j.rcsop.2024.100489. eCollection 2024 Sep.
Australia has a notable gap in guidance for pharmacists, caregivers and disability service providers in: (i) supporting people with disabilities (PWD) within the medication management cycle, (ii) understanding their obligations for providing high quality care, and (iii) preventing medication-related harm.
The objective of this study was to identify medication management issues for PWD from the perspective of disability caregivers and pharmacists when supporting PWD with their medication.
A qualitative study design using semi-structured interviews of pharmacists and disability caregivers was undertaken across six different states or territories in Australia.
Interviews were conducted with registered pharmacist participants (n=10), and disability workers (n=10). Seven themes emerged for both pharmacists and caregivers, with most sub-themes and codes concordant between the two cohorts. Clinical issues, particularly related to polypharmacy and psychotropic use; confidence in providing medicines and medication information accurately to PWD; practical and behavioural issues caregivers experienced when administering medication; challenges in providing individualised and person-centred care to PWD; inadequate communication and transfer of information between healthcare professionals, caregivers, and PWD; insufficient disability awareness training for pharmacists and medication training for caregivers; and challenges working with provider organisations within the current practice environment were described.
This study highlighted seven areas where issues were perceived to arise in medication management for PWD. By understanding the issues perceived by those directly providing care, it may be possible to improve medication management. Further research is needed to understand the perceived role of pharmacists in supporting medication management for PWD and their caregivers, and how enabling pharmacists scope might reduce medication-related risks and support QUM in this sector.
澳大利亚在为药剂师、护理人员和残疾服务提供者提供指导方面存在显著差距，具体体现在：（i）在药物管理周期内为残疾人提供支持；（ii）理解他们提供高质量护理的义务；（iii）预防与药物相关的伤害。
本研究的目的是从残疾护理人员和药剂师在为残疾人提供药物支持时的角度，识别残疾人的药物管理问题。
采用定性研究设计，对澳大利亚六个不同州或地区的药剂师和残疾护理人员进行半结构化访谈。
对注册药剂师参与者（n = 10）和残疾工作者（n = 10）进行了访谈。药剂师和护理人员都出现了七个主题，两个群体之间的大多数子主题和编码一致。描述了临床问题，特别是与多重用药和精神药物使用相关的问题；准确向残疾人提供药品和药物信息的信心；护理人员在给药时遇到的实际和行为问题；为残疾人提供个性化和以人为本护理的挑战；医疗保健专业人员、护理人员和残疾人之间信息沟通和传递不足；药剂师的残疾意识培训不足以及护理人员的药物培训不足；以及在当前实践环境中与服务提供组织合作的挑战。
本研究突出了残疾人药物管理中被认为存在问题的七个领域。通过了解直接提供护理的人员所感知的问题，可能有助于改善药物管理。需要进一步研究以了解药剂师在支持残疾人及其护理人员药物管理方面所感知的作用，以及扩大药剂师的职责范围如何降低与药物相关的风险并支持该领域的优质用药管理。
